ADIPS-NOVO NORDISK RESEARCH GRANTS
Applications for the 2026 ADIPS-Novo Nordisk Research Grant are now open.
Applications close: 11:59 pm, 25 October 2026
Please note: In order to apply for this grant, applicants must be financial members of ADIPS.
Check your membership is current or join now on the ADIPS website at www.adips.org.
This research grant is available in the broad areas of Clinical, Scientific or Education Research. This grant is an encouragement award in the field of Diabetes in Pregnancy and is for A$10,000.
The grant funds may be suitable for pilot studies but are not intended to fund large scale projects or salaries. Priority will be given to new investigators, novel submissions, and proposals which are not additional studies within existing funded projects.
It is expected that projects will be completed within one year and that the successful applicants should undertake to present their findings at the ADIPS Annual Scientific Meeting in the following 1–2 years.
The application should be in PDF format and not more than 2 pages (excluding references) and MUST be submitted to the Executive Officer Uma Subramanian at eo@adips.org.
Please include in the Subject line: 'Application for the 2026 ADIPS-Novo Nordisk Research Grant - your surname'
Applications must indicate:
Grant Title
Grant Category (Clinical, Scientific or Educational)
Investigators
Project details
Institution and contact
Significance of the project
A detailed project budget (Essential)
In addition, the following questions need to be answered:
Is this proposal a component or sub-study of a larger project with existing funding or where funding from another body has been sought
Name of the administering body.
The successful applicants will be notified by December 2026 with the funding available for projects to commence in the following January.
Further enquiries should be directed to the Executive Officer, ADIPS via email to eo@adips.org
We extend our gratitude to Novo Nordisk for their ongoing support over many years of this grant scheme.
